AstraZeneca Pharmaceuticals Positions on U.S. Legislation - MapLight

AstraZeneca Pharmaceuticals Positions on U.S. Legislation

AstraZeneca Pharmaceuticals Positions on U.S. Legislation - MapLight
AstraZeneca Pharmaceuticals Positions on U.S. Legislation
Published Oct 23, 2020
98 pages — Published Oct 23, 2020
Price US$ 125.00  |  Buy this Report Now

About This Report

  
Abstract:

AstraZeneca Pharmaceuticals Bill Positions
MapLight's report on AstraZeneca Pharmaceuticals details AstraZeneca Pharmaceuticals's support for or opposition to bills in Congress. MapLight has recorded 20 bill positions taken by AstraZeneca Pharmaceuticals since January 1, 2007. These bills relate to topics including Government Operations and Politics, Health, Business and Commerce, Budget, Spending, and Taxes, Legal Issues, and 43 other topics.
Support and opposition information is based on public documents found by MapLight, including congressional testimony, news reports, and company statements. These documents are included with the report.

Scope:
This report provides, for each of the 20 bills AstraZeneca Pharmaceuticals has taken a position on, the following information:
* Bill name, number, and sponsor.
* Bill summary and status (i.e. whether the bill is in committee, has become law, etc.).
* AstraZeneca Pharmaceuticals's position (support or opposition).
* Date AstraZeneca Pharmaceuticals's position was taken and date it was recorded by MapLight.
* Source document for the support or opposition stance.

Source documents:
Source documents for AstraZeneca Pharmaceuticals's support or opposition stance are authored by:
* United States Senate Committee on Finance; 2nd Company letter to Senate on Tax Extenders (10 pages)
* United States Senate Committee on Finance; Business Leaders Back Baucus Effort on Extenders (10 pages)
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* Invest in America's Future; Company, Organization Letter to Congress on the R&D Tax Credit (7 pages)
* R&D Credit Coalition; R&D Credit Coalition Applauds House Introduction of Bipartisan Bill to Spur Innovation, Create Jobs & Boost GDP (5 pages)
* Patents Matter; Coalition Statement (2 pages)
* Patents Matter; Coalition Statement (2 pages)
* Letters and Testimonies; TO THE MEMBERS OF THE UNITED STATES CONGRESS: (11 pages)
* Patents Matter; HR 2024 Misses the Target While Threatening Innocent Patent Owners (7 pages)
* And others.

Reasons to buy:
* Gauge future potential of AstraZeneca Pharmaceuticals based on whether a bill they support or oppose advances or is defeated in Congress.
* Evaluate the political activity of AstraZeneca Pharmaceuticals, including legislation of interest.
* Understand the reasoning behind AstraZeneca Pharmaceuticals's positions on legislation through content of source documents.
* Learn of other organizations that have taken the same position as AstraZeneca Pharmaceuticals on a bill (other signers).
* Learn of legislation which affects the financial prospects of AstraZeneca Pharmaceuticals.
* Learn whether bills AstraZeneca Pharmaceuticals has supported or opposed have been enacted, defeated, or are still pending.

Topics of legislation:
The bills AstraZeneca Pharmaceuticals has taken a position on cover the following topics: Government Affairs (13), Business & Labor (11), Health & Welfare (11), Science, Technology, Communications, and Infrastructure (11), Budget & Economy (10), Legal Affairs (9), Culture and Social Issues (6), Defense, National Security and Foreign Policy (5), Natural Resources (5), Education (3). The report is 98 pages long, including 21 source documents.

  
Source:
Document ID
9307288000
Industry
Format:
PDF Adobe Acrobat
Buy Now

MapLight—Company positions on U.S. legislation reports detail support for and opposition to bills in the U.S. Congress, for the most politically active companies, unions, associations, and interest groups. The reports are based on public documents, including company statements, news reports, and congressional testimony. These documents are included with the reports.

About the Author


Cite this Report

  
MLA:
MapLight. "AstraZeneca Pharmaceuticals Positions on U.S. Legislation" Oct 23, 2020. Alacra Store. Nov 15, 2026. <http://www.alacrastore.com/storecontent/MapLight/AstraZeneca-Pharmaceuticals-Positions-on-U-S-Legislation-2154-45>
  
APA:
MapLight. (2020). AstraZeneca Pharmaceuticals Positions on U.S. Legislation Oct 23, 2020. New York, NY: Alacra Store. Retrieved Nov 15, 2026 from <http://www.alacrastore.com/storecontent/MapLight/AstraZeneca-Pharmaceuticals-Positions-on-U-S-Legislation-2154-45>
  
US$ 125.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Company Profiles from one place.